|
GNPNAT1 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.62458935193399E-12 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
<1E-12 |
| Normal-vs-Stage2 |
3.30580000040825E-07 |
| Normal-vs-Stage3 |
2.258300E-03 |
| Normal-vs-Stage4 |
2.001700E-03 |
| Stage1-vs-Stage2 |
8.256600E-01 |
| Stage1-vs-Stage3 |
8.076400E-03 |
| Stage1-vs-Stage4 |
1.448010E-01 |
| Stage2-vs-Stage3 |
5.559600E-02 |
| Stage2-vs-Stage4 |
3.440400E-01 |
| Stage3-vs-Stage4 |
4.668400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
<1E-12 |
| Normal-vs-AfricanAmerican |
1.62525548574877E-12 |
| Normal-vs-Asian |
2.944000E-01 |
| Caucasian-vs-AfricanAmerican |
9.656600E-01 |
| Caucasian-vs-Asian |
1.936640E-01 |
| AfricanAmerican-vs-Asian |
4.127800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
<1E-12 |
| Normal-vs-Female |
6.52739995388174E-09 |
| Male-vs-Female |
6.405300E-04 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
2.87236900931021E-12 |
| Normal-vs-Extreme_Weight |
7.54951656745106E-15 |
| Normal-vs-Obese |
4.5129455727988E-12 |
| Normal-vs-Extreme_Obese |
1.58269997108107E-09 |
| Normal_Weight-vs-Extreme_Weight |
5.159000E-01 |
| Normal_Weight-vs-Obese |
5.908000E-01 |
| Normal_Weight-vs-Extreme_Obese |
3.537600E-01 |
| Extreme_Weight-vs-Obese |
2.392200E-01 |
| Extreme_Weight-vs-Extreme_Obese |
6.924400E-01 |
| Obese-vs-Extreme_Obese |
2.470000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.320020E-01 |
| Normal-vs-Age(41-60Yrs) |
1.11022302462516E-16 |
| Normal-vs-Age(61-80Yrs) |
<1E-12 |
| Normal-vs-Age(81-100Yrs) |
2.77555756156289E-14 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.094170E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.292200E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.007780E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.282600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.449600E-04 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.700700E-03 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
1.62447832963153E-12 |
| Normal-VS-Type2 PRCC |
6.99440505513849E-15 |
| Normal-VS-KIRP CIMP |
3.966000E-01 |
| Normal-VS-Unclassified PRCC |
1.63957736276643E-12 |
| Type1 PRCC-VS-Type2 PRCC |
3.034800E-01 |
| Type1 PRCC-VS-KIRP CIMP |
1.162790E-03 |
| Type1 PRCC-VS-Unclassified PRCC |
8.112800E-01 |
| Type2 PRCC-VS-KIRP CIMP |
8.59400000052801E-07 |
| Type2 PRCC-VS-Unclassified PRCC |
5.357000E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
1.219430E-03 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
<1E-12 |
| Normal-vs-N1 |
1.567360E-01 |
| Normal-vs-N2 |
3.08159999962143E-07 |
| N0-vs-N1 |
7.97190000000336E-05 |
| N0-vs-N2 |
7.370000E-01 |
| N1-vs-N2 |
3.994400E-02 |
|
|
